Concepedia

Matus Studeny

MS

Statistics

Publications

17

Citations

3.4K

H-Index

17

Active since

1994

Affiliations

Boehringer Ingelheim (Germany)(Current)

Boehringer Ingelheim (France)

Vall d'Hebron Hospital Universitari

The University of Texas MD Anderson Cancer Center

National Cancer Center Hospital East

Matus Studeny is an author at Boehringer Ingelheim (Germany) specializing in oncology, medicine, and cancer pharmacology.

Publications per year

1994–2025

17

Publications

17

Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas

Akira Nakamizo, Frank C. Marini, Toshiyuki Amano et al. · Cancer Research · 2005 · 1K citations

, , +8

Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

Matus Studeny, Frank C. Marini, Richard E. Champlin et al. · PubMed · 2002 · 907 citations

, , +17

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

Matus Studeny, F. Marini, Jennifer L. Dembinski et al. · JNCI Journal of the National Cancer Institute · 2004 · 842 citations

, , +15

Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer

Jennifer L. Dembinski, S. Wilson, Erika L. Spaeth et al. · Cytotherapy · 2013 · 85 citations · Full text

, , +15

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

Eric Van Cutsem, Takayuki Yoshino, Heinz‐Josef Lenz et al. · Annals of Oncology · 2018 · 64 citations · Full text

, , +12

1–5 of 17